Viewing Study NCT06440850


Ignite Creation Date: 2025-12-24 @ 5:07 PM
Ignite Modification Date: 2026-02-20 @ 6:46 PM
Study NCT ID: NCT06440850
Status: RECRUITING
Last Update Posted: 2025-12-05
First Post: 2024-04-19
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Vemurafenib and Cobimetinib for the Treatment of Patients With High Risk Differentiated Thyroid Carcinoma With BRAFV600E Mutation
Sponsor: City of Hope Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Thyroid Gland Follicular Carcinoma View
None Thyroid Gland Oncocytic Carcinoma View
None Thyroid Gland Papillary Carcinoma View
Keywords: